1. Manola J et al. Prognostic factors in metastatic melanoma: a pooled analysis of Eastern Cooperative Oncology Group Trials. J Clin Oncology 2000; 18: 3782–93.
2. Satyamoorthy K et al. Cancer Res 2001; 61: 7318–24.
3. Richmond A et al. Cancer Res 1982; 42: 3175–801; Albino AP. Cancer Res 1991; 51: 4815–20.
4. Meier F et al. Exp Dermat 2003; 12: 296–306.
5. Gartside MG et al. Proc Am Ass Cancer Res Ann Meeting April 16, 2005; abs 2588.
6. Halaban R et al. Oncogene 1992; 7: 62195–206.
7. Noonan FP et al. Cancer Res 2000; 60: 3738–43.
8. Figure KA et al. Proc Nat Ac Sc USA 2001; 98: 10722–7.
9. Wyman K et al. Proc Am Sc Oncol 2003; 22: 713 abs. 2865.
10. Carson WE et al. Proc Am Sc Oncol 2003; 22: 715, abst. 2873.
11. Green CL, Khavari PA. Semin Cancer Biol 2004; 14: 63–9.
12. Van’t Veer LJ et al. Mol Cell Biol 1989; 9: 3114–6.
13. Eskandarpour M et al. J Na.l Cancer Inst 2003; 95: 790–8.
14. Davies H et al. Nature 2004; 17: 949–954; Green CL, Khavari PA. Semin Cancer Biol 2004; 14: 63–9.
15. Dong J et al. Cancer Res 2003; 63: 3883–5.
16. Tsao H et al. J Invest Dermat 2004; 122: 337–41.
17. Sansal I, Sellers WR. J Clin Oncol 2004; 22: 2954–63.
18. Hingorani SR et al. Cancer Res 2003; 63: 5198–202; Sumimoto et al. Oncogene 2004; 23: 6031–9; Eskandarpour M et al. Int J Cancer 2005; 115: 65–73.
19. Escudier CS et al. J Clin Oncol 2005; 24: 380s abst. LAB4510.
20. Wilhelm SM et al. Cancer Res 2004; 64: 7099–109.
21. Wellbrock C et al. Cancer Res 2004; 64: 2338–42.
Ahmad T. et al., J. Clin. Oncol. 2004; 22:711s, abst. 7506; Flaherty K.T. et al., J. Clin. Oncol. 2005; 23: 201s, abs. 3037
22. Eisen Е et al. J Clin Oncol 2005; 24: 712s abst. 7508; Flaherty KT et al. J Clin Oncol 2005; 24: 201s abst. 3037; Flaherty KT et al. J Clin Oncol 2004; 22: 711s abst.7507; Flaherty KT et al. Proc Am Soc Clin Oncol 2003; 22: 177s abst. 710.
23. Sebolt-Lepold JS et al. Nat Med 1999; 5: 810–6.
24. Rinehart О et al. J Clin Oncol 2004; 22: 4456–62.
25. Menon SS et al. J Clin Oncol 2005; 2: 208s. abs. 3066.
26. Solit DB et al. Nature 2006; 439: 358–62.
27. Lorusso P et al. J Clin. Oncol 2005; 23: 194 abs. 3011.
28. Wilhelm SM et al. Cancer Res 2004; 64: 7099–109, McDaid HM et al. Cancer Res 2005; 65: 2854–60; Taxman DJ et al. Cancer Res 2003; 63: 5095–104.
29. Robertson GP. Cancer Metastasis Rev 2005; 24: 273–85; Amiry KI et al. Cancer Metastasis Rev 2005; 24: 301–13.
30. Liu ZJ, Herlyn M. In: Cancer: Principles & Practice of Oncology. 7th ed. Lippincott Williams & Wilkins; 2004; 1745–53.
31. Stahl JM et al. Cancer Res 2004; 64: 7002–10.
32. Molhoek KR et al. J Transl Med 2005; 3: 39.
33. Margolin KA et al. J Clin Oncol 2004; 22: 715. abst. 7523.
34. Romano MF et al. Eur J Cancer 2004; 40: 2829–36.
35. Stahl JM. Cancer Res 2004; 64: 7002–10.
36. Amiri KI et al. Cancer Res 2004; 64: 4912–8.
37. Markovic SN et al. Cancer 2005; 103: 2584–9.
38. Grbovic OM et al. Proc Nat Acad Sc. USA. 2006; 103: 57–62.
39. Fang D et al. Cancer Res 2005; 65: 9328–37.
40. Frank NY et al. Cancer Res 2005; 65: 4320–3; Patrawala I et al. Cancer Res 2005; 65: 6207–19.
41. Michor А еt al. Nature 2005; 435: 1267–70.